Sherlock Biosciences raises $80M Series B for at-home diagnostics
Sherlock Biosciences announced today that it raised $80 million in a Series B financing round to support its next-generation diagnostics.
Stay updated with breaking news from Bryan Dechairo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sherlock Biosciences announced today that it raised $80 million in a Series B financing round to support its next-generation diagnostics.
Diagnostics developer Sherlock Biosciences has advanced its molecular diagnostic capabilities, which can now produce faster results on low-cost devices. The startup will use its Series B round of funding to expand the reach of its technology, potentially placing it directly in the hands of consumers around the world.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!